We analyzed the expression distribution of Sesn2 in respect to their clinicopathological categories such as squamous-cell carcinoma, adenocarcinoma and small cell carcinoma as well as sex, age and the grade of cell differentiation, we found there is no significant difference of Sesn2 expression under those categories (details see S2 Table). This evidence concerns the gene SESN2 and squamous cell carcinoma.